Janney Montgomery Scott’s Aquestive Therapeutics AQST Stock Holding History

Janney Montgomery Scott’s Portfolio AQST Stock Details AQST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.6M	Buy	1,106,160 +17,050	+2%	+$71.8K	0.01%	1016
2026 Q1	$4.52M	Sell	1,089,110 -4,100	-0.4%	-$16.6K	0.01%	881
2025 Q4	$7.06M	Sell	1,093,210 -6,633	-0.6%	-$41.3K	0.02%	745
2025 Q3	$6.15M	Buy	1,099,843 +46,783	+4%	+$202K	0.01%	796
2025 Q2	$3.49M	Sell	1,053,060 -6,700	-0.6%	-$19.2K	0.01%	964
2025 Q1	$3.07M	Buy	1,059,760 +75,275	+8%	+$228K	0.01%	975
2024 Q4	$3.5M	Buy	984,485 +61,200	+7%	+$282K	0.01%	909
2024 Q3	$4.6M	Buy	923,285 +42,800	+5%	+$167K	0.01%	795
2024 Q2	$2.29M	Buy	880,485 +538,625	+158%	+$1.8M	0.01%	1042
2024 Q1	$1.46M	Buy	+341,860	New	+$1.14M	﹤0.01%	1311

Other funds holding AQST

BCM

Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Janney Montgomery Scott's AQST Position: Q2 2026 in Review

Janney Montgomery Scott increased its Aquestive Therapeutics (AQST) stake by 1.6% in Q2 2026, buying an estimated $71.8K and bringing the position to 1,106,160 shares worth $4.6M. The position accounts for 0.01% of the portfolio, ranked #1016.

Janney Montgomery Scott first reported a position in AQST in Q1 2024 and has held it in 10 quarters since. The position peaked at $7.06M in Q4 2025. 185 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

Janney Montgomery Scott held 1,106,160 shares of Aquestive Therapeutics worth $4.6M as of Q2 2026.
Janney Montgomery Scott bought 17,050 Aquestive Therapeutics shares in Q2 2026, an estimated $71.8K.
Aquestive Therapeutics made up 0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #1016 holding.
Janney Montgomery Scott first reported a position in Aquestive Therapeutics in Q1 2024 and has held it in 10 quarters since.
Janney Montgomery Scott's Aquestive Therapeutics position peaked at $7.06M in Q4 2025.
185 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.